Dr. Chirag Shah MBBS , MD (Internal Medicine), Diplomate American Board of Hematology & Medical Oncology

Apollo Hospital, Ahmedabad

25 Years Experience

Dr. Chirag A. Shah – Medical Oncologist

MBBS, MD (Internal Medicine), Diplomate American Board of Hematology & Medical Oncology

Professional Summary

Dr. Chirag A. Shah is a distinguished Medical Oncologist, Hematologist, and Director of the Department of Cancer, Blood Diseases, and Stem Cell Transplant at Apollo Hospital, Ahmedabad, with over 25 years of comprehensive oncology experience. As one of the few American Board Certified specialists in both Hematology and Medical Oncology in India, Dr. Shah has established himself as Gujarat's leading cancer care expert. With 7 years of continuous training in the USA and board recertification placing him in the top 20 percentile worldwide, he brings internationally recognized expertise to comprehensive cancer treatment, having cared for over 18,000 patients throughout his distinguished career.

Hospital Affiliations

Apollo Hospital, Gandhinagar-Ahmedabad

Hospital Features:

• State-of-the-art bone marrow transplant unit
• Advanced chemotherapy and immunotherapy facilities
• Comprehensive cancer diagnostic and treatment services
• Multidisciplinary tumor board for treatment planning
• Palliative care and supportive oncology programs

Professional Distinctions:

• Only expert in Gujarat state to hold American Board Certification in both Hematology and Medical Oncology
• One of very few in India with dual American Board Certification
• Top 20 percentile worldwide in recertification examinations
• 7 years continuous training in USA at premier cancer center

Professional Memberships

• American Board of Internal Medicine – Diplomate in Hematology
• American Board of Internal Medicine – Diplomate in Medical Oncology
• Various Cancer Research Societies – Active participation in clinical trials

Specialization Areas

Medical Oncology - Comprehensive Cancer Treatment

Breast Cancer:

• Early-stage and advanced breast cancer management
• Neoadjuvant and adjuvant chemotherapy
• Targeted therapy (HER2-positive breast cancer)
• Hormone receptor-positive treatment protocols
• Triple-negative breast cancer specialized care

Lung Cancer:

• Small cell and non-small cell lung cancer treatment
• Targeted therapy for EGFR, ALK, ROS1 mutations
• Immunotherapy for lung cancer
• Combination chemotherapy protocols

Gastrointestinal Cancers:

• Colorectal cancer management
• Gastric and esophageal cancer treatment
• Pancreatic cancer protocols
• Hepatobiliary malignancies

Genitourinary Cancers:

• Bladder cancer treatment
• Kidney cancer management
• Prostate cancer therapy
• Testicular cancer protocols

Gynecological Cancers:

• Ovarian cancer treatment
• Cervical cancer management
• Endometrial cancer protocols

Head & Neck Cancers:

• Oral cavity and oropharyngeal cancers
• Laryngeal cancer treatment
• Nasopharyngeal cancer management

Other Solid Tumors:

• Brain tumors (gliomas, glioblastomas)
• Sarcomas (bone and soft tissue)
• Melanoma and skin cancers
• Neuroendocrine tumors

Hematology & Blood Disorders

Blood Cancers:

• Acute myeloid leukemia (AML)
• Acute lymphoblastic leukemia (ALL)
• Chronic myeloid leukemia (CML)
• Chronic lymphocytic leukemia (CLL)
• Multiple myeloma
• Hodgkin lymphoma
• Non-Hodgkin lymphoma
• Myelodysplastic syndromes (MDS)

Non-Malignant Blood Disorders:

• Aplastic anemia
• Thalassemia major and intermedia
• Sickle cell disease
• Immune thrombocytopenic purpura (ITP)
• Hemophilia and bleeding disorders
• Anemia of various causes

Stem Cell Transplant / Bone Marrow Transplant

• Autologous Transplant – For multiple myeloma, lymphomas
• Allogeneic Transplant – For leukemias, aplastic anemia, thalassemia
• Matched Sibling Transplant
• Matched Unrelated Donor (MUD) Transplant
• Haploidentical Transplant
• Pre-transplant evaluation and preparation
• Post-transplant care and monitoring
• Graft-versus-host disease (GVHD) management

Advanced Cancer Therapies

• Targeted Therapy – Precision medicine based on molecular profiling
• Immunotherapy – Checkpoint inhibitors, CAR-T cell therapy coordination
• Chemotherapy – All standard and novel protocols
• Hormone Therapy – For breast, prostate cancers
• Palliative Care – Comprehensive supportive oncology for advanced cancers

Treatment Philosophy

Dr. Shah's core principle is "Patient First" with pillars of "Quality", "Ethics", and "Care":

• Result-Oriented Care – Focus on measurable outcomes and patient benefit
• Team Building – Creating best-in-class multidisciplinary teams
• International Standards – Applying USA-trained expertise to patient care
• Comprehensive Approach – From curative treatment to palliative care
• Evidence-Based Medicine – Following latest oncology research and guidelines

Advanced Treatment Capabilities

1. Stem Cell Transplantation Program

• Comprehensive transplant services for blood cancers
• Thalassemia major curative transplant
• Aplastic anemia transplant protocols
• Autologous transplant for myeloma and lymphoma
• Post-transplant long-term follow-up

2. Precision Oncology

• Molecular profiling of tumors
• Targeted therapy selection based on mutations
• Personalized treatment protocols
• Clinical trial coordination

3. Immunotherapy Programs

• Checkpoint inhibitor therapy
• CAR-T cell therapy coordination
• Combination immunotherapy protocols
• Immune-related adverse event management

4. Supportive & Palliative Care

• Comprehensive symptom management
• Pain control and quality of life focus
• Nutritional support during treatment
• Psychosocial support for patients and families
• End-of-life care with dignity

Support Services

• Comprehensive cancer diagnosis and staging
• Chemotherapy administration (inpatient and outpatient)
• Targeted therapy and immunotherapy infusions
• Bone marrow transplant coordination
• Nutritional counseling for cancer patients
• Pain management and palliative care
• Genetic counseling for hereditary cancers
• Clinical trial enrollment opportunities
• Survivorship care and follow-up programs
• Second opinion consultations for complex cases

Reopine Consultation Details

Available Services:
✅ First Opinion Consultations – Initial cancer evaluation and treatment planning
✅ Second Opinion Reviews – Complex oncology case assessment
✅ Chemotherapy Planning – Protocol selection and management
✅ Bone Marrow Transplant Evaluation – Transplant candidacy assessment
✅ Blood Disorder Management – Comprehensive hematology consultations
✅ Palliative Care Planning – Advanced cancer supportive care strategies

Languages Spoken:

• English (Fluent)
• Hindi (Fluent)
• Gujarati (Native)

Book Your Consultation

Ready to receive world-class cancer care from Gujarat's most qualified medical oncologist?

Dr. Chirag A. Shah offers comprehensive oncology consultations through Reopine's secure virtual platform, providing American Board-certified expertise in cancer treatment, blood disorders, and bone marrow transplantation with a patient-first approach.

Request your consultation today to access 25+ years of internationally trained oncology expertise and result-oriented cancer care.

Last Updated: Feb 2026
Profile prepared for Reopine